title: C-reactive protein inhibits in vitro oxidation of low-density lipoprotein.
abstract: C-reactive protein (CRP) is elevated in cardiovascular disease and binds to oxidized phosphatidylcholine (oxPtC) in the low-density lipoprotein (LDL) surface. In the present study, we tested if CRP influences the susceptibility of LDL to oxidation. At physiological concentrations of 1-7mug/ml, CRP strongly inhibited copper-mediated oxidation of LDL and phospholipid liposomes in a concentration-dependent manner. Similar concentrations of different monoclonal antibodies or albumin did not influence LDL oxidation. Antioxidant activity of CRP was inhibited by phosphocholine (PC), indicating that the observed activity involves binding of CRP to oxPtC. These results suggest that CRP may limit atherogenic oxidation of LDL in vivo.
authors.affiliation: Department of Biochemistry, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, 23298, USA.
authors.forename: Miguel L
authors.initials: ML
authors.lastname: Rufail
authors.forename: Samuel C
authors.initials: SC
authors.lastname: Ramage
authors.forename: Rik
authors.initials: R
authors.lastname: van Antwerpen
mesh_terms: D000911:Antibodies, Monoclonal / Q000737:chemistry; D050197:Atherosclerosis / Q000378:metabolism; D002097:C-Reactive Protein / Q000737:chemistry* / Q000378:metabolism; D003300:Copper / Q000737:chemistry*; D006801:Humans; D008077:Lipoproteins, LDL / Q000737:chemistry* / Q000378:metabolism; D008081:Liposomes; D010084:Oxidation-Reduction; D010713:Phosphatidylcholines / Q000737:chemistry / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D008077:Lipoproteins, LDL; D008081:Liposomes; D010713:Phosphatidylcholines; D003300:Copper; D002097:C-Reactive Protein